| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 03/02/1999 | US5876730 Heparin-binding growth factor (HBGF) polypeptides |
| 03/02/1999 | US5876712 Immune reactivity to HER-2/neu protein for diagnosis and treatment of malignancies in which the HER-2/neu oncogene is associated |
| 03/02/1999 | US5876695 Nuclear magnetic resonance contrast agent |
| 03/02/1999 | CA2242252A1 Dexb |
| 03/02/1999 | CA2175458C Novel benzenesulfonylimine derivatives as inhibitors of il-1 action |
| 03/02/1999 | CA1340417C Monoclonal antibodies specific to human epidermal growth factor receptor and therapeutic methods employing same |
| 03/01/1999 | CA2242311A1 Novel compounds |
| 02/28/1999 | CA2246407A1 Use of inhibitors of the sodium-hydrogen exchanger for the production of a pharmaceutical for the treatment of disorders which are caused by protozoa |
| 02/27/1999 | CA2245776A1 Pharmaceutical combination preparation of an inhibitor of the sodium/hydrogen exchanger and a medicament for the treatment of cardiovascular diseases |
| 02/25/1999 | WO1999009182A2 Rab proteins |
| 02/25/1999 | WO1999009168A1 Testis-specific transcription factor zgcl-1 |
| 02/25/1999 | WO1999009162A2 Delayed progression to aids by a missense allele of the ccr2 gene |
| 02/25/1999 | WO1999009157A1 POLYPEPTIDE HAVING A GTPase REGULATOR ACTIVITY, NUCLEIC ACIDS CODING THEREFOR AND THEIR USE IN DIAGNOSTICS AND THERAPY |
| 02/25/1999 | WO1999009156A2 Protease-related protein |
| 02/25/1999 | WO1999009155A1 70 human secreted proteins |
| 02/25/1999 | WO1999009064A1 Epitope-bearing major histocompatibility complex class ii element/immunoglobulin chimeric molecules |
| 02/25/1999 | WO1999009063A1 Interleukin-18 binding proteins, their preparation and use |
| 02/25/1999 | WO1999009061A1 Secreted proteins |
| 02/25/1999 | WO1999009052A1 Chemical modification of proteins to improve biocompatibility and bioactivity |
| 02/25/1999 | WO1999009051A1 Method for the induction of proteins with therapeutic effect |
| 02/25/1999 | WO1999009031A1 Nucleosides analogues, such as antivirals including inhibitors of retroviral reverse transcriptase and the dna polymerase of hepatitis b virus (hbv) |
| 02/25/1999 | WO1999009030A1 Naphthyridinones for inhibiting protein tyrosine kinase and cell cycle kinase mediated cellular proliferation |
| 02/25/1999 | WO1999009027A1 (hetero)aryl-sulfonamide derivatives, their preparation and their use as factor xa inhibitors |
| 02/25/1999 | WO1999009025A2 2-(4-aryl or heteroaryl-piperazin-1-ylmethyl)-1h-indole derivatives interacting with the dopamine d4 receptor |
| 02/25/1999 | WO1999009022A1 Furansulfonic acid derivatives and pharmaceutical compositions containing the same |
| 02/25/1999 | WO1999009017A1 Solid and liquid-phase synthesis of benzoxazoles and benzothiazoles and their use |
| 02/25/1999 | WO1999009016A1 Substituted quinazoline derivatives and their use as tyrosine kinase inhibitors |
| 02/25/1999 | WO1999009015A1 2-{3-[4-(2-t-butyl-6- trifluoromethylpyridin-4-yl) piperazin-1-yl] propylmercapto} pyrimidin-4-ol-fumarate |
| 02/25/1999 | WO1999009006A1 SYNTHESIS OF CLASTO-LACTACYSTIN β-LACTONE AND ANALOGS THEREOF |
| 02/25/1999 | WO1999009005A1 Hiv matrix protein tyrosine position 29 pocket binders |
| 02/25/1999 | WO1999009003A1 3-aryl-succinamido-hydroxamic acids, methods for producing said acids and medicaments containing the same |
| 02/25/1999 | WO1999008992A1 2,4-pentadienoic acid derivatives having retinoid-like biological activity |
| 02/25/1999 | WO1999008987A1 Cyclohexenone long-chain alcohol and medicament containing same |
| 02/25/1999 | WO1999008708A2 Method and food product for increasing muscle protein and reducing fat in animals |
| 02/25/1999 | WO1999008702A1 Methods for treatment of patients afflicted wih multiple sclerosis using consensus interferon |
| 02/25/1999 | WO1999008700A1 pRb2/p130 PEPTIDE INHIBITORS OF cdk2 KINASE ACTIVITY |
| 02/25/1999 | WO1999008690A1 Method of enhancing bioavailability of fexofenadine and its derivatives |
| 02/25/1999 | WO1999008685A1 Phosphono-carboxylate compounds for treating amyloidosis |
| 02/25/1999 | WO1999008684A2 Solutions containing azasteroids |
| 02/25/1999 | WO1999008682A1 A method of preventing or treating estrogen-dependent diseases and disorders |
| 02/25/1999 | WO1999008677A1 METHODS FOR INHIBITING DETRIMENTAL SIDE-EFFECTS DUE TO GnRH OR GnRH AGONIST ADMINISTRATION |
| 02/25/1999 | WO1999008676A1 Compositions containing bergamottin for increasing the oral bioavailability of pharmaceutical agents |
| 02/25/1999 | WO1999008668A2 Combination of tyrosine kinase inhibitor and chemical castration to treat prostate cancer |
| 02/25/1999 | WO1999008666A2 Pharmaceutical composition comprising an azateroid |
| 02/25/1999 | WO1999008539A1 Novel phytase |
| 02/25/1999 | WO1999008533A1 Central nervous system axon regeneration |
| 02/25/1999 | WO1999008519A1 Polyamine treatment of neurological disorders |
| 02/25/1999 | WO1998053050A3 Short peptides which selectively modulate the activity of serine/threonine kinases |
| 02/25/1999 | WO1998052915A3 Leukotriene b4 derivatives, in particular oximo-ltb4 antagonists |
| 02/25/1999 | WO1998042659A3 Aryl- or heteroarylsulfonamide substituted hydroxamic acid derivates, process for their preparation and their use as pharmaceuticals |
| 02/25/1999 | WO1998032017A3 Modulators of insulin receptor activity |
| 02/25/1999 | DE19837386A1 New CCR-3 antagonist piperazine derivatives and analogues |
| 02/25/1999 | CA2301796A1 70 human secreted proteins |
| 02/25/1999 | CA2301297A1 2-{3-[4-(2-t-butyl-6- trifluoromethylpyridin-4-yl) piperazin-1-yl] propylmercapto} pyrimidin-4-ol-fumarate |
| 02/25/1999 | CA2301227A1 Solid and liquid-phase synthesis of benzoxazoles and benzothiazoles and their use |
| 02/25/1999 | CA2301054A1 Synthesis of clasto-lactacystin .beta.-lactone and analogs thereof |
| 02/25/1999 | CA2301043A1 Testis-specific transcription factor zgcl-1 |
| 02/25/1999 | CA2300995A1 Methods for inhibiting detrimental side-effects due to gnrh or gnrh agonist administration |
| 02/25/1999 | CA2300912A1 3-aryl-succinamido-hydroxamic acids, methods for producing said acids and medicaments containing the same |
| 02/25/1999 | CA2300878A1 Central nervous system axon regeneration |
| 02/25/1999 | CA2300805A1 Polypeptide having a gtpase regulator activity, nucleic acids coding therefor and their use in diagnostics and therapy |
| 02/25/1999 | CA2300801A1 Rab proteins |
| 02/25/1999 | CA2300694A1 Furansulfonic acid derivatives and pharmaceutical compositions containing the same |
| 02/25/1999 | CA2300093A1 Delayed progression to aids by a missense allele of the ccr2 gene |
| 02/25/1999 | CA2299291A1 Method and food product for increasing muscle protein and reducing fat in animals |
| 02/25/1999 | CA2298855A1 Interleukin-18 binding proteins, their preparation and use |
| 02/25/1999 | CA2295023A1 Solutions containing azasteroids |
| 02/25/1999 | CA2295016A1 Pharmaceutical composition |
| 02/25/1999 | CA2241390A1 Pigrl-1, a member of immunoglobulin gene superfamily |
| 02/25/1999 | CA2239260A1 Human disintegrin metalloprotease related to drosophila kuz gene |
| 02/24/1999 | EP0897983A2 Antibody against CD40-L |
| 02/24/1999 | EP0897979A2 Human sdr2 cdna clone |
| 02/24/1999 | EP0897915A1 Quinazolinone conpounds as chemotherapeutic agents |
| 02/24/1999 | EP0897914A1 Process for the preparation of 2,5-disubstitued pyridines |
| 02/24/1999 | EP0897913A1 4-carboxamido piperidine derivatives and their use as neurokinine antagonists |
| 02/24/1999 | EP0897912A1 Amidino derivatives useful as nitric oxide synthase inhibitors |
| 02/24/1999 | EP0897908A1 3-Aryl-succinamido-hydroxamic acids, process for their preparation and medicaments containing them |
| 02/24/1999 | EP0897721A2 Benzo(b)thiophene derivatives for inhibiting detrimental side-effects due to GnRH or GnRH agonist administration |
| 02/24/1999 | EP0897424A1 Human membrane antigen tm4 superfamily protein and dna encoding this protein |
| 02/24/1999 | EP0897303A1 Inhibitors of farnesyl-protein transferase |
| 02/24/1999 | EP0789707A4 Amino acid nucleic acids |
| 02/24/1999 | EP0703904B1 Pyrimidine cyanoguanidines as k-channel blockers |
| 02/24/1999 | CN1209139A Prodrugs of thrombin inhibitors |
| 02/24/1999 | CN1209129A Antagonists of gonadotropin releasing hormone |
| 02/24/1999 | CN1209127A Tricyclic amides useful for inhibition of G-protein function and for treatment of proliferative diseases |
| 02/24/1999 | CN1209125A Piperazine derivatives as tachykinin antagonists |
| 02/24/1999 | CN1209123A New barbituric acid derivatives, processes for their prodn. and pharmaceutical agent contg. same |
| 02/24/1999 | CN1209119A Novel tricyclic compounds and drug compositions contg. same |
| 02/24/1999 | CN1209117A N-acylaminoalkylhydrzinecarboximidamides |
| 02/24/1999 | CN1209064A Combination therapy for osteoporosis |
| 02/24/1999 | CN1209063A Vitronection receptor antagonists |
| 02/24/1999 | CN1209060A Vitronectin receptor antagonists |
| 02/24/1999 | CN1208653A Medicine for treating carsickness and method for preparing same |
| 02/24/1999 | CN1208648A Chinese herb medicine allicin health-care liquid |
| 02/24/1999 | CN1208631A Method for strengthening yang |
| 02/24/1999 | CN1208629A Health-care tea for promoting blood circulation and lowering blood pressure and method for preparing same |
| 02/24/1999 | CN1042226C Heterocyclic derivatives and method for preparing the salt thereof |
| 02/23/1999 | US5874585 Substituted heterocyclic compounds useful as inhibitors of (serine proteases) human neutrophil elastase |
| 02/23/1999 | US5874583 Treating depression, obsessive compulsive disorder, stuttering, trichotillomania |
| 02/23/1999 | US5874561 DNA, host cell and vector encoding a protein with cytokine inhibitory activity |